The Journal of Clinical Endocrinology & Metabolism · 1981 · 41 citations · 0 references
Life SciencesBiochemistryEndocrinologyHepatologyHormone BiochemistryNeuroendocrinologyEndocrine BiochemistryGrowth HormoneMammalian EndocrinologyPituitary Gland FunctionPituitary HormonesDose ResponseEnzyme EffectsGrowth Hormone DetectionGrowth Hormone MeasurementGrowth Hormone ReceptorsPituitary Hormone AssaysPotency MeasurementRelative Potency Ratio
We report herein the presence of extractable levels of immunoassayable (RIA) and receptor-assayable human GH (hGH)-like material in normal human liver, kidney, lung, striated muscle, colon, stomach, and brain. Levels of hGH by RIA were the highest in the liver (mean, 14.7 ng/g), followed by those in the kidney (mean, 11.3 ng/g) and lung (mean, 4.6 ng/g), but small amounts were detected in at least some specimens of all types of tissue. This material eluted in the region of monomeric pituitary hGH on Sephadex G-100 chromatography and showed parallelism in a RIA to pituitary hGH on log-logit plots of dose-response lines. Passage of the material through an anti-hGH immunocolumn greatly reduced its immunoreactivity. Assay of eight sets of extracts by receptor assay using a male rat liver membrane preparation showed the GH-like substance to have a receptor to immunoassay potency ratio of 3.8:1 relative to monomeric hGH standard. Scrupulous correction for acidity, osmolality, and possible protein and enzyme effects and extraction of the hGH-like material by immunoabsorption excluded the possibility of artifacts causing the appearance of hGH-like material in the extracts.